{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T17:02:40Z","timestamp":1648832560153},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1991,1,1]],"date-time":"1991-01-01T00:00:00Z","timestamp":662688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[1991,1]]},"DOI":"10.1007\/bf01643761","type":"journal-article","created":{"date-parts":[[2005,5,7]],"date-time":"2005-05-07T08:36:02Z","timestamp":1115454962000},"page":"49-53","source":"Crossref","is-referenced-by-count":3,"title":["In-vitro susceptibility of cefoperazone-susceptible and -resistant gram-negative rods to cefoperazone plus sulbactam, other beta-lactams, aminoglycosides and quinolone"],"prefix":"10.1007","volume":"19","author":[{"given":"P. H.","family":"Chandrasekar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Sluchak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0732-8893(85)80005-5","volume":"3","author":"R. N. Jones","year":"1985","unstructured":"Jones, R. N., Wilson, H. W., Thornsberry, C., Barry, A. L. In vitro antimicrobial activity of cefoperazone-sulbactam combinations against 554 clinical isolates including a review and \u03b2-lactamase studies. Diagn. Microbiol. Infect. Dis. 3 (1985) 489\u2013499.","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/0732-8893(89)90138-7","volume":"12","author":"G. P. Bodey","year":"1989","unstructured":"Bodey, G. P., Miller, P. Ho, D. H. In vitro assessment of sulbactam plus cefoperazone in the treatment of bacteria isolated from cancer patients. Diagn. Microbiol. Infect. Dis. 12 (1989) 2095\u20132145.","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"CR3","first-page":"287","volume":"7","author":"K. P. Fu","year":"1987","unstructured":"Fu, K. P., Neu, H. C. Synergistic activity of cefoperazone in combination with \u03b2-lactamase inhibitors. J. Antimicrob. Chemother. 7 (1987) 287\u2013290.","journal-title":"J. Antimicrob. Chemother."},{"key":"CR4","first-page":"1655","volume":"12","author":"J. Klastersky","year":"1989","unstructured":"Klastersky, J., Van der Auwera, P. H. In vitro activity of sulbactam in combination with various \u03b2-lactam antibiotics. Diagn. Microbiol. Infect. Dis. 12 (1989) 1655\u20131695.","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/jac\/17.4.463","volume":"17","author":"K. E. Aldridge","year":"1986","unstructured":"Aldridge, K. E., Sanders, C. V., Marier, R. L. Variation in the potentiation of \u03b2-lactam antibiotic activity by clavulanic acid and sulbactam against multiple antibiotic-resistant bacteria. J. Antimicrob. Chemother. 17 (1986) 463\u2013469.","journal-title":"J. Antimicrob. Chemother."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0732-8893(84)90039-7","volume":"2","author":"R. Bolivar","year":"1984","unstructured":"Bolivar, R., Weaver, S. S., Bodey, G. P. Activity of \u03b2-lactamase inhibitors in combination with new \u03b2-lactam antibiotics against resistant gram-negative organisms. Diagn. Microbiol. Infect. Dis. 2 (1984) 255\u2013260.","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1128\/JCM.25.9.1725-1729.1987","volume":"25","author":"R. N. Jones","year":"1987","unstructured":"Jones, R. N., Barry, A. L., Packer, R. R., Gregory, W. W., Thornsberry, C. In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sullbactam combination. J. Clin. Microbiol. 25 (1987) 1725\u20131729.","journal-title":"J. Clin. Microbiol."},{"issue":"Suppl. 5C","key":"CR8","first-page":"2","volume":"80","author":"J. Klastersky","year":"1986","unstructured":"Klastersky, J. Concept of empiric therapy with antibiotic combinations. Am. J. Med. 80 (Suppl. 5C) (1986) 2\u20139.","journal-title":"Am. J. Med."},{"issue":"Suppl. 3","key":"CR9","doi-asserted-by":"crossref","first-page":"S 513","DOI":"10.1093\/clinids\/7.Supplement_3.S513","volume":"7","author":"J. F. Acar","year":"1985","unstructured":"Acar, J. F. Therapy for lower respiratory tract infections with imipenem\/cilastatin: a review of worldwide experience. Rev. Infect. Dis. 7 (Suppl. 3) (1985) S 513-S 517.","journal-title":"Rev. Infect. Dis."},{"issue":"Suppl. 1","key":"CR10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/clinids\/10.Supplement_1.S57","volume":"10","author":"H. C. Neu","year":"1988","unstructured":"Neu, H. C. Bacterial resistance to fluoroquinolones. Rev. Infect. Dis. 10 (Suppl. 1) (1988) 57\u201363.","journal-title":"Rev. Infect. Dis."},{"key":"CR11","doi-asserted-by":"crossref","first-page":"215 S","DOI":"10.1016\/0732-8893(89)90139-9","volume":"12","author":"A. Horicuhi","year":"1989","unstructured":"Horicuhi, A., Hasegawa, H., Kageyama, T., Yonezawa, T., Kitani, T., Masaoka, T., Yasunaga, K., Kawagoe, H., Nagai, K. Efficacy of sulbactam\/cefoperazone for the treatment of infections in patients with hematologic diseases. Diagn. Microbiol. Infect. Dis. 12 (1989) 215 S-219 S.","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/AAC.32.4.503","volume":"32","author":"D. P. Reitburg","year":"1988","unstructured":"Reitburg, D. P., Marble, D. A., Schultz, P. W., Whall, T. J., Schentag, J. J. Pharmacokinetics of cefoperazone (2.0g) and sulbactam (1.0g) coadministered to subjects with normal renal functions, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis. Antimicrob. Agents Chemother. 32 (1988) 503\u2013509.","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01643761.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01643761\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01643761","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T07:50:43Z","timestamp":1586245843000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01643761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1991,1]]}},"alternative-id":["BF01643761"],"URL":"https:\/\/doi.org\/10.1007\/bf01643761","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,1]]}}}